Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy
Article in Life Sciences (June 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia
Article in Journal of Cellular and Molecular Medicine (May 2023)
Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold
Article in European Journal of Medicinal Chemistry (April 2023)